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Background: Several systematic reviews and meta-analyses demonstrated the association between depression and
the risk of coronary heart disease (CHD), but the previous reviews had some limitations. Moreover, a number of
additional studies have been published since the publication of these reviews. We conducted an updated
meta-analysis of prospective studies to assess the association between depression and the risk of CHD.
Methods: Relevant prospective studies investigating the association between depression and CHD were
retrieved from the PubMed, Embase, Web of Science search (up to April 2014) and from reviewing reference lists
of obtained articles. Either a random-effects model or fixed-effects model was used to compute the pooled risk
estimates when appropriate.
Results: Thirty prospective cohort studies with 40 independent reports met the inclusion criteria. These groups
included 893,850 participants (59,062 CHD cases) during a follow-up duration ranging from 2 to 37 years. The pooled
relative risks (RRs) were 1.30 (95% CI, 1.22-1.40) for CHD and 1.30 (95% CI, 1.18-1.44) for myocardial infarction (MI). In the
subgroup analysis by follow-up duration, the RR of CHD was 1.36 (95% CI, 1.24-1.49) for less than 15 years follow-up,
and 1.09 (95% CI, 0.96-1.23) for equal to or more than 15 years follow-up. Potential publication bias may exist, but
correction for this bias using trim-and-fill method did not alter the combined risk estimate substantially.
Conclusions: The results of our meta-analysis suggest that depression is independently associated with a significantly
increased risk of CHD and MI, which may have implications for CHD etiological research and psychological medicine.
Keywords: Depression, Coronary heart disease, Myocardial infarction, Meta-analysisBackground
Cardiovascular disease (CVD) is now a public health cri-
sis in both developed and developing countries. It is the
leading cause of mortality and extorts heavy social and
economic costs globally [1,2]. Although regular physical
activity and maintenance of a healthy diet (and health
weight) are probably the most crucial ways to prevent
the disease [3-5], mental health status may provide an
additional preventive strategy against CHD risk.
Depression is a common mental disorder, which usu-
ally causes severe disability and imposes a huge burden
of disease on individuals, families and societies [6]. It is
estimated that 5.8% of men and 9.5% of women will* Correspondence: hai_tao_cao@163.com; zuxunlu@yahoo.com
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unless otherwise stated.experience a depressive episode in any given year [6]. De-
pression is highly prevalent in the world. The average life-
time prevalence of depression has been estimated at 14.6%
in high-income countries, 11.1% in low-to middle-income
countries [7]. According to the estimate by World Health
Organization (WHO), depression will become the second
leading cause of disability-adjusted life years lost by the
year 2020 [8]. During the past decades, a large body of epi-
demiological studies suggested that depression was associ-
ated with an increased risk of chronic diseases [9],
including CHD.
Previous reviews [10-14] showed that depression has
been associated with CHD, but they had some limita-
tions. In 1987, the first meta-analysis [10] showed that
depression was an risk factor for CHD, but most of the
studies included in that review were cross-sectional in
design [11], which maybe have more confounding bias.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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strongest evidence in observational studies. Prospective
data to exclude some possible sources of bias that may
exist in retrospective data could do good to come to
more definitive conclusions. Rugulies [11] showed that
depression was a predictor for coronary heart disease
based on cohort studies, while the review did not fully
investigate other subgroups except for the type of de-
pression measurement. Other two meta-analyses [12,13]
were published on this topic in the past 10 years and the
most recent one was published in 2007. The meta-
analysis [14] in 2007 reported a pooled relative risk esti-
mated of 1.48 (95% CI, 1.29–1.69) for CHD, which
focused on the cardiovascular outcomes and took pooled
effect size of CHD from 16 studies published before
2005 as a secondary analysis. Furthermore, the review
did not exclude those studies that participants were with
CHD at the study baseline, which did not clearly enable
reader to discern the depression as pre-morbid risk fac-
tor, and affected the magnitude of the true association.
Potential publication bias was also not fully explored in
this review. Since the publication of the last review on
this topic, many more prospective studies have emerged,
which allowed to perform more detailed analysis for new
insights and obtain more powerful evidence on the asso-
ciation between depression and CHD risk. Given the
limitations of previous reviews and the higher level of
evidence from prospective cohort studies, along with the
additional recent studies, it was necessary for us to as-
sess the association between depression and the risk of
CHD by conducting an updated meta-analysis based on
prospective cohort studies.Methods
Search strategy
We performed this systematic review in accordance
with the Meta-analysis of Observational Studies in
Epidemiology (MOOSE) guidelines [15]. A literature
search of PubMed, Embase and Web of Science from
their inception to April 2014 for prospective cohort
studies describing the association between depression
status (defined by self-reported scales, clinician/phys-
ician diagnosis, or structured clinical diagnostic inter-
view) and the risk of CHD was conducted. We used
the following search terms “depression,” “depressive
symptoms,” “depression disorder,” and “coronary heart
disease” or “ischemic heart disease” or “myocardial in-
farction” [MeSH] or “cardiovascular diseases” [MeSH]
combined with “cohort studies” “follow-up studies”
“prospective studies” “longitudinal studies”. In addition,
the reference lists of all identified relevant publications
and relevant reviews were reviewed. Only articles pub-
lished in English were considered.Selection criteria
Studies were included in the meta-analysis if they met the
following criteria: (1) the study was a population-based or
community-based prospective cohort study design; (2) the
exposure of interest was depression symptoms; (3) the
outcome of interest was CHD or MI; (4) participants were
free of CHD at study entry; (5) the study reported the risk
estimates with 95% confidence interval (CI) for the associ-
ation between depression and CHD. Studies were ex-
cluded if (1) the study had a retrospective design; (2) the
estimates were presented without standard errors or other
information that allowed calculation of standard errors;
(3) no confounders were adjusted for. In the case of mul-
tiple publications from the same study, only the most re-
cent paper or article with a longer follow-up was included.
Data extraction
We extracted the following information from each re-
trieved study: name of the first author, year of publication,
study location, characteristics of study population at base-
line, duration of follow-up, definition and measurement of
exposure, outcomes, number of cases, size of cohort, ad-
justed relative risk (RR) with 95% CI, and covariates that
were adjusted in the multivariable analysis. Data extrac-
tion was conducted independently by two authors (Y.G.
and Y.H.G). Interobserver agreement was assessed using
Cohen kappa (κ), and any differences were resolved by
discussion with the third author (Z.X.L.).
Quality assessment
To determine the validity of included studies, two re-
viewers (Y.G. and Y.H.G.) independently performed the
quality assessment by using the Newcastle-Ottawa Scale
[16], which is a validated scale for non-randomized studies
in meta-analyses [17]. The Newcastle-Ottawa Scale is a
nine-point scale that allocates points based on the selec-
tion process of cohorts (0–4 points), the comparability of
cohorts (0–2 points), and the identification of the expos-
ure and the outcomes of study participants (0–3 points).
We assigned scores of 0–3, 4–6, and 7–9 for low, moder-
ate, and high quality of studies, respectively. Each study
was rated independently by two authors (Y.G. and Y.H.
G.); ratings were reported in Additional file 1: Table S1.
Statistical analysis
In this meta-analysis, the RR was used as a common
measure of the association between depression and the
risk of CHD, and the hazard ratios (HRs) was considered
equivalent to RRs. If articles provided RRs for women
and men separately, we pooled both risk estimates to
obtain one overall estimates for the primary analysis. If
studies reported fatal or nonfatal outcomes, the two
outcomes were considered as two independent reports
respectively for all analysis. To be consistent across
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and CHD. We did not include studies using depressive
scale as a continuous variable because the risk estimates
were not comparable with those using categorized depres-
sion measures.
The heterogeneity among studies was estimated by the
Cochran Q test and I2 statistic. P < 0.10 was considered
indicative of statistically significant heterogeneity. Statis-
tical heterogeneity among studies was evaluated using
the I2 statistic, where values of 25%, 50% and 75% repre-
sent cut-off points for low, moderate and high degrees
of heterogeneity, respectively [18]. When appropriate,
we used a fixed-effects model or random-effects model.
The RRs were pooled using the fixed-effects model if no
heterogeneity was detected, or the random-effects model
was used otherwise [19].
We conducted stratified analyses and sensitive analyses
to evaluate the influences of study and population charac-
teristic on study results. We used the Begg test [20], the
Egger test [21] and visual inspection of a funnel plot to
assess the publication bias. The Duval and Tweedie non-
parametric trim-and-fill method [22] was performed to
further assess the potential publication bias. All analyses
were performed with STATA statistical software version
11.0 (STATA Corp, College Station, TX, USA). All tests
were two sided with a significance level of 0.05.
Results
Literature search and study selection
Initially, 9022 articles from the PubMed, Embase, and
Web of Science were identified. The majority were ex-
cluded after the first screening of titles or abstracts, be-
cause they were duplicates, reviews, case–control studies,
cross-sectional studies, or not relevant to our analysis.
After assessing full texts for detailed evaluation, 30 studies
[23-52] met the inclusion criteria and were included in the
meta-analysis. A flow chart showing the study selection
was presented in Figure 1. Interobserver agreement (κ)
was 0.959, which indicated a very outstanding concord-
ance between raters for article inclusion decisions [53].
The quality of studies was generally good, with results of
study quality assessment yielded a score of 6 or above for
all included studies, with an average score of 7.8.
Study characteristics
Additional file 1: Table S1 showed the main characteris-
tics of 30 prospective cohort studies included that were
published between 1993 and 2014. With regard to study
location, fifteen studies were conducted in the United
States, twelve in European countries (one of the twelve
studies was a multi-country study), one each in Hong
Kong, Taiwan, and Canada. The study samples ranged
from 660 to 345,949, with a total of 893,850, and the
follow-up durations ranged from 2 to 37 years. Thenumber of CHD cases diagnosed in the primary studies
ranged from 45 to 11,659, with 59,062 reported CHD
outcomes (two studies [24,54] did not report the number
of CHD cases). Twenty-three studies reported results for
both men and women, six reported results for men and
women separately (The result of one study is only avail-
able for men [33]), five studies reported results for men
only, and two studies reported results for women only.
One study [44] reported results by time interval: 0 to
5 year and 5 to 10 year. Three studies [23,29,46] re-
ported the outcome of fatal and nonfatal CHD simultan-
eously. The assessment of depression varied across
studies, twenty-two studies administered a validated
questionnaire of depression symptoms, in which nine
different self-reported symptom scales were repre-
sented in Additional file 1: Table S1. Twelve of twenty-
two studies used the Center for Epidemiology Studies
Depression scale (CESD). Of the 30 studies, 24 reported
CHD outcomes and 12 reported MI outcomes. The
proportion of major depression or scoring above the
cutoff of self-rating instruments ranged from 1.3 to
50.6% (average 17.5%). The prevalence rate of depres-
sion symptoms was much higher than clinical diagno-
sis. Outcome ascertainment was from a variety of
sources, such as medical records, self-report, register
database, National Death Index, clinical diagnoses, and
death certificates. The major adjustment confounding
factors included age, sex, smoking, alcohol intake, physical
activity, body mass index (BMI), diabetes, hypertension
and cholesterol.
Association between depression and the risk of all CHD
events
Thirty studies with 39 reports were included in the ana-
lysis of depression and CHD risk. The results from
random-effects meta-analysis of depression and the risk of
CHD were shown in Figure 2. Of the 39 reports, 21
showed a significantly positive relationship between de-
pression and the risk of CHD, while the other reports did
not. The pooled RR of CHD for depression was 1.30 (95%
CI, 1.22–1.40). Substantial heterogeneity was observed
(P < 0.001; I2 = 71.9%).
Association of depression with the risk of MI
The results from random-effects meta-analysis of depres-
sion and the risk of MI were shown in Figure 3. Of the 12
studies, 8 showed a significant positive association be-
tween depression and MI risk, and 4 suggested no statisti-
cally significant association of interest. The pooled RR was
1.30 (95% CI, 1.18–1.44), and there was a moderate to
high heterogeneity (P = 0.001; I2 = 64%). Visual inspection
of the Begg funnel plot did not identify substantial asym-
metry. Neither the Begg test nor the Egger test for publi-
cation bias reached significance (P > 0.05 for both tests).
Figure 1 Flow chart of study selection.
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sive symptoms score was used as a continuous variable.
We added the RR from the study to the main analysis of
MI, and the pooled RR was 1.26 (95 CI%, 1.16 to 1.37).
Thus, our results would not change even if the study
was included.
Subgroup analyses
Table 1, Additional file 1: Table S2 and S3 showed the re-
sults from subgroup analyses examining the stability of
the primary results and exploring the resource of hetero-
geneity. The associations between depression and the riskof CHD and MI were similar in most subgroup analyses,
which were stratified by sex, mean age at baseline, publi-
cation year (before 2005 vs. after 2005), duration of
follow-up, study location, type of depression measure, and
whether smoking, BMI, diabetes, hypertension, physical
activity, cholesterol or socioeconomic status were con-
trolled or not in models. However, moderate to high het-
erogeneities were observed in most subgroups. The
increased CHD risk was more evident in the groups of less
than 15 years follow-up and adjusted for hypertension. No
significant between-group difference was found for other
variable (see Additional file 1: Table S2 and S3).
Figure 2 Forest plot of depression and the risk of coronary heart disease.
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Sensitivity analyses were performed to detect potential
sources of heterogeneity in the association between depres-
sion and the risk of CHD, and to examine the influence of
various exclusion criteria on the combined risk estimate. Ex-
clusion of 3 studies that their outcomes were CHD plus MI
showed a greater risk 1.35 (95% CI, 1.22–1.50), and statis-
tical heterogeneity was forcefully attenuated (P =0.001, I2=
52.8%). Exclusion of the study by Cohen et al. that enrolled
patients with hypertension yielded a pooled RR of 1.29 (95%
CI, 1.17-1.43; P < 0.001). We excluded any single study in
turn and pooled the results of the remaining studies. The
overall combined RR did not change substantially, with arange from 1.29 (95% CI, 1.17 to 1.42; P <0.001) to 1.34
(95%CI, 1.21 to 1.48; P <0.001).
Two studies [56,57] were excluded because depressive
symptoms score was used as a continuous variable rather
than a binary variable. We added the RRs from the two
studies to the main analysis of CHD, and the results did
not change substantially (RR, 1.25; 95% CI, 1.16 to 1.34).
Publication bias
Visual inspection of the Begg funnel plot did not re-
veal any asymmetry. The Begg test was not significant
(z = 1.13; P = 0.26), which identified no evidence of
substantial publication bias, but the Egger test did not
Figure 3 Forest plot of depression and the risk of myocardial infarction.
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method was performed with 5 imputed studies, which
produced a symmetrical funnel plot (see Figure. 4). The
corrected RR using the trim-and-fill method was 1.25
(95% CI, 1.14–1.38; P < 0.001). Correction for potential
publication bias therefore did not alter the combined risk
estimate substantially.
Discussion
The results of our meta-analysis of 30 prospective cohort
studies with 40 independent reports suggest that depres-
sion is associated with a significantly increased risk of
CHD and MI. Participants with depression, compared
with those free of it, experienced a significant increased
risk of 30% for CHD and MI. Furthermore, the association
remained significant in the groups adjusted for poten-
tial confounders, such as lifestyle factors and socio-
demographic factors.
Comparison with previous studies
The present meta-analysis showed that the pooled ad-
justed RRs were 1.30 (95% CI, 1.22–1.40), 1.30 (95% CI,
1.18–1.44) for CHD and MI, respectively, which weremuch lower than those from a previous meta-analysis
published 2007 for CHD (RR, 1.48; 95% CI, 1.29–1.69)
and for MI (RR, 1.60; 95% CI, 1.34–1.92). Our meta-
analysis included 19 new prospective cohort studies with
larger sample size and many more cases, which signifi-
cantly enhanced statistical power to detect the potential
associations of depression with CHD and MI. In
addition, we also fully explored the potential publication
bias. Although potential publication bias may exist, cor-
rection for this bias using trim-and-fill method remained
statistically significant. More important, compared with
the previous meta-analysis in 2007, the associations dif-
fered between populations of different ethnic back-
grounds was investigated. We found that the association
trended to be stronger for participants from the United
States than for European participants. There was null
statistically significant risk of CHD in Hong Kong, which
might result from the limited number of included stud-
ies (One study with two reports comprising 62,839
participants). Given that the studies included in our
meta-analysis were conducted in affluent countries
(areas) in North America, Western Europe, and Hong
Kong, the results should not be extended to developing
Table 1 Subgroup analyses of relative risk of coronary heart disease
No of reports Relative risk (95% CI) I2 P for heterogeneity
Coronary heart disease
Primary analysis 27* 1.31 1.19 to 1.45 70.50% <0.001
Subgroup analyses for coronary heart disease
Sex
Men 13 1.38 1.17 to 1.61 74.60% <0.001
Women 8 1.17 1.01 to 1.36 55.50% 0.028
Combined 13 1.36 1.17 to 1.57 56.50% 0.006
Mean age at baseline, y
≥65 13 1.35 1.14 to 1.59 81.20% <0.001
<65 21 1.3 1.17 to 1.44 61.40% <0.001
Publication year
Before 2005 15 1.47 1.23 to 1.75 62.30% 0.001
2005-2014 19 1.24 1.13 to 1.37 74.30% <0.001
Duration of follow-up
≥15 years 4 1.09 0.96 to 1.23 0.00% 0.714
<15 years 30 1.36 1.24 to 1.49 74.80% <0.001
Study location
Unite States, Canada 21 1.39 1.24 to 1.56 53.20% 0.002
Europe 11 1.18 1.06 to 1.32 69.70% <0.001
Asia 2 1.14 0.77 to 1.70 81.20% 0.021
Type of depression measurement
Self-reported scales 29 1.33 1.22 to 1.46 74.30% <0.001
Clinical diagnosis 4 1.2 0.82 to 1.74 60.00% 0.058
Combined 1 1.12 0.89 to 1.41 NA NA
Abbreviations: NA, not applicable.
*Five articles provided RRs for women and men separately, we pooled both risk estimates to obtain one overall estimates for the primary analysis; therefore, there
are 27 reports in the primary analysis.
Figure 4 Filled funnel of relative risk of studies that investigated the association between depression and the risk of coronary
heart disease.
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populations, more studies conducted in other populations
from Asia, Africa and South America are warranted.
Our subgroups analyses identified two important and
valuable findings. A major finding was that depression
increased the risk of CHD in the group of less than
15 years follow-up, but did not have statistically signifi-
cant association for equal to or more than 15 years
follow-up, which was a very interesting phenomenon.
One possible explanation to this finding was that most
studies have usually measured depression only one time
at the beginning of the study, and have assessed the out-
comes at the end of the follow-up. It was well known
that depression was treatable and depressive individuals
could recover during the follow-up. The longer the
follow-up duration, the more people could recover,
which might weaken the association between depression
and CHD risk. In turn, the finding confirmed that the
depression was associated with CHD risk.
Another finding was that depression could be an inde-
pendent risk factor for CHD. In our subgroup analyses,
studies adjusted for smoking, BMI, hypertension, diabetes,
physical activity, and socioeconomic status did not influ-
ence the result of positive association, which suggested
that adequate adjustment was not definite to weaken the
pooled effect estimate and conclusion [58].
In the subgroup analysis type of depression measure-
ment, it was notable that the association was much
stronger in these studies that identified depression
using self-reported scales rather than structured clinical
diagnostic interviews or clinical diagnosis. One possible
interpretation was that the estimates of depression may
differ depending on the use of dimensionally versus
categorically based depression assessment tools [59]. Struc-
tured psychiatric interviews would definitely exclude indi-
viduals with subsyndromal depressive symptoms from case
status. Conversely, utilization of self-reported symptom
scales would allow the inclusion of a lot of people with clin-
ically significant depressive symptoms who failed to meet
formal criteria for diagnostic and statistical manual of men-
tal disorders (DSM) diagnosis, but a large body of evidence
showed that subsyndromal depressive symptoms, like clin-
ical syndromes, were significantly associated with adverse
functional outcomes, disability, morbidity and mortality
[60]. Therefore, inclusion of people with subsyndromal
depression in the reference category may weaken the risk
estimates of studies with categorically based depression def-
inition. More important, there were quite clear differences
present that go opposite to a dose–response association
between depression and CHD. The interesting finding de-
serves attention from related researchers. More studies in-
vestigating the association between depression and CHD
risk based on the use frequency of self-report instruments
and interviews over time are needed, which will help toexplore the dose–response relationship with them. Spe-
cially, in our meta-analysis, a majority of studies defined
depression status by self-reported symptom scales, thus
our findings much more trended to generalize to the pop-
ulations who had depression symptoms.
On the basis of our research findings, it was expected
that treatment with antidepressants would reduce the risk
of development of CHD. Conversely, some observational
studies [40,61] suggested treatment with antidepressants
was associated with increasing risk of CHD. However, the
results should be interpreted cautiously because medication
use could be a marker of depression severity [62], evidence
from a meta-analysis of clinical trials showed that treatment
with antidepressants was beneficial for CHD [63]. Thus, pa-
tients with antidepressants medication use were more likely
to have severe depressive symptoms, and the increased risk
of CHD may be attributable to depression severity rather
than the antidepressant medication use.
Interestingly, although the evidence from observational
studies on the association between depression and the risk
of CHD seemed to be robust, the evidence from random-
ized controlled trials (RCTs) did not find an effect of the
intervention [64,65]. We noted that evidence from RCTs
had suggested that the treatment response and medical
prognosis of different patient subgroups appear different
[66]. For example, among post–acute coronary syndrome
patients, depression, particularly if mild, might be moni-
tored for remission without treatment. On the contrary,
persistent depression, particularly if treatment recalcitrant,
should be treated, taking into considering the link to
adverse post-acute coronary syndrome outcomes [66]. In
addition, studies suggested that gender might play a differ-
ent role in affecting the medical outcomes from psycho-
therapy [67,68]. Therefore, more research is needed to
further investigate the prognosis of subgroups based on
depression severity and/or onset and gender, which would
help to reveal the relationship between depression and
CHD.
Study strengths and limitations
Our review is very valuable and crucial though it is an
updated meta-analysis. Firstly, we not only included the
prospective cohort studies, also included 19 more new
studies and 759,922 more new participants than the pre-
vious reviews, which provided stronger and more suffi-
cient evidence. Secondly, on the basis of our subgroup
analysis, an important methodological finding was worth
paying attention to. In cohort studies with longer follow-
up, exposure (such as depression) might be mutative, but
the exposure measurement frequency was often inadequate,
which should arouse the investigator’s attention in the
population-based observational epidemiological studies.
A few limitations of our meta-analysis should be ac-
knowledged. Firstly, we observed robust and consistent
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lyses and subgroup analyses. Yet as a limitation, there was
the evidence of heterogeneity across the studies used for
the analysis of association between depression and the risk
of CHD. The heterogeneity might result from the differ-
ence of participants’ characteristic, sample sizes, study de-
signs, and diagnostic criteria of depression. Thus, the
results of this meta-analysis should be interpreted cau-
tiously. Secondly, the measurement of depression mostly
used the self-reported symptom scales, which could cause
the misclassification of exposure [9], and might underesti-
mate the reported association. Thirdly, the publication
bias were observed, however, we used trim-and-fill
method to correct the bias, which did not obviously alter
the positive association. Fourthly, the receipt and type of
depression treatment were not taken into consideration,
and many studies lacked information on depression treat-
ment and antidepressant medication use. The role of de-
pression treatment in modulating subsequent risk of CHD
needs to be studied further.
Suggestions for further studies
On the basis of our findings, we put forward some sugges-
tions for future studies. Firstly, more studies are needed to
assess depression in a repeated-measures design with diag-
nostic interview as well as self-report during the follow-up.
Secondly, in order to achieve stronger research evidence,
investigators should strive to improve the standardization
of their depression measurement and outcome definitions
[69]. Thirdly, we should inquire the variation of depression
of participants at the end of the follow-up, and further ac-
curately assess the association between depression and the
risk of CHD. Finally, more interventional studies are needed
to explore the underlying mechanisms and to determine the
cause and effect relationships that link depression and CHD.
Conclusion
In conclusion, our meta-analysis of prospective studies
suggests that depression is probably an independent risk
factor, which is associated with a 30% increase risk for
CHD and MI. Given the high prevalence of depression in
the general population and the heavy economic burden of
CHD, it is greatly important for us to take depression
account into the clinical prevention and treatment of CHD.
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